gatifloxacin has been researched along with gentamicin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Dawis, MA; France, KA; Isenberg, HD; Jenkins, SG | 1 |
| Bentzel, DE; Brook, I; Elliott, TB; Keller, CE; Knudson, GB; Shoemaker, MO | 1 |
| Evangelista, AT; Jones, ME; Karlowsky, JA; Sahm, DF; Thornsberry, C; Yee, YC | 1 |
| Hiratsuka, Y; Kobayakawa, S; Murakami, A; Tochikubo, T; Watabe, Y | 1 |
| Abdelbacki, AMM; El-Gebaly, RH; Fadel, MA; Mohamed, SA | 1 |
| Abd Ellah, NH; Abdelmoez, A; Abouelmagd, SA; Amen, O; Mohamed, NG | 1 |
| Boonmars, T; Laummaunwai, P; Sanpool, O; Thongseesuksai, T; Wongwai, P | 1 |
7 other study(ies) available for gatifloxacin and gentamicin
| Article | Year |
|---|---|
In vitro activity of gatifloxacin alone and in combination with cefepime, meropenem, piperacillin and gentamicin against multidrug-resistant organisms.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Cefepime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Fluoroquinolones; Gatifloxacin; Gentamicins; Meropenem; Microbial Sensitivity Tests; Penicillins; Piperacillin; Thienamycins | 2003 |
Antimicrobial therapies for pulmonary Klebsiella pneumoniae infection in B6D2F1/J mice immunocompromised by use of sublethal irradiation.
Topics: Animals; Anti-Bacterial Agents; Ceftriaxone; Drug Combinations; Female; Fluoroquinolones; Gatifloxacin; Gentamicins; Humans; Immunocompromised Host; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred Strains; Pneumonia, Bacterial; Survival Rate; Whole-Body Irradiation | 2004 |
Stable antimicrobial susceptibility rates for clinical isolates of Pseudomonas aeruginosa from the 2001-2003 tracking resistance in the United States today surveillance studies.
Topics: beta-Lactams; Ceftazidime; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gatifloxacin; Gentamicins; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; United States | 2005 |
Comparison of the influence of intracameral gentamicin, gatifloxacin, and moxifloxacin on the corneal endothelium in a rabbit model.
Topics: Animals; Anterior Chamber; Anti-Bacterial Agents; Aza Compounds; Endothelium, Corneal; Fluoroquinolones; Gatifloxacin; Gentamicins; Microscopy, Electron, Scanning; Models, Animal; Moxifloxacin; Quinolines; Rabbits | 2010 |
Biophysical control of the growth of Agrobacterium tumefaciens using extremely low frequency electromagnetic waves at resonance frequency.
Topics: Agrobacterium tumefaciens; Amikacin; Anti-Bacterial Agents; Carbenicillin; Cefaclor; Chloramphenicol; Ciprofloxacin; DNA, Bacterial; Electromagnetic Radiation; Fluoroquinolones; Gatifloxacin; Gentamicins; Plant Tumors; Rifampin; Solanum lycopersicum | 2017 |
Self-assembled tannic acid complexes for pH-responsive delivery of antibiotics: Role of drug-carrier interactions.
Topics: Anti-Bacterial Agents; Colistin; Drug Carriers; Drug Liberation; Escherichia coli; Gatifloxacin; Gentamicins; Hydrogen-Ion Concentration; Models, Molecular; Staphylococcus aureus; Tannins | 2019 |
Evaluating the in vitro efficacy of gatifloxacin, levofloxacin and gentamicin against Acanthamoeba cysts.
Topics: Acanthamoeba; Amebiasis; Animals; Eye Infections, Parasitic; Gatifloxacin; Gentamicins; Humans; Levofloxacin; Ophthalmic Solutions | 2020 |